Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Neoadjuvant sEphB4-HSA in Patients With Genitourinary Cancers

NCT02767921 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT02767921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02767921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Neoadjuvant sEphB4-HSA in Patients With Genitourinary Cancers
Lead sponsor
University of Southern California
Phase
Phase 1
Overall status
Terminated
Start date
August 2, 2016
Completion date
November 15, 2021
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infiltrating bladder urothelial carcinoma, recurrent bladder carcinoma, stage i prostate cancer, stage i renal cell cancer, stage ii bladder urothelial carcinoma, stage ii renal cell cancer, stage iia prostate cancer, stage iib prostate cancer, stage iii prostate cancer, stage iii renal cell cancer